Ancylostomiasis clinical trials
The registry lists 35 studies for Ancylostomiasis across more than 10 countries. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-14.
Status
- Completed
- 29
- Status unknown
- 2
- Not yet recruiting
- 1
- Active, not recruiting
- 1
- Withdrawn
- 1
- Terminated
- 1
Phase
- Phase 1
- 9
- Phase 2
- 7
- Phase 3
- 5
- Phase 4
- 2
Where
- Tanzania
- 9
- United States
- 5
- Brazil
- 4
- Netherlands
- 3
- Côte D'Ivoire
- 3
- United Kingdom
- 2
Who runs them
Baylor College of Medicine (8) · Jennifer Keiser (8) · Swiss Tropical & Public Health Institute (4) · Albert B. Sabin Vaccine Institute (3) · Leiden University Medical Center (2) · University of Nottingham (2) · London School of Hygiene and Tropical Medicine (1) · Swiss Federal Institute of Technology (1)
Studies
Recruiting first, then most recently updated. Showing 35 of 35 — search for more.
- Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth InfectionsNot yet recruitingNCT06800248Phase 31 country
- Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth InfectionsActive, not recruitingNCT06736691Phase 31 country
- Efficacy, Safety and Acceptability of Ivermectin ODT in PSACCompletedNCT06184399Phase 21 country
- Efficacy and Safety of Moxidectin-Albendazole Co-administration in SACCompletedNCT06188715Phase 31 country
- Safety and Immunogenicity Study of Na-GST-1 With or Without CpGCompletedNCT02143518Phase 11 country
- Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris TrichiuraCompletedNCT06720259Phase 21 country
- Evaluating Impact of Improved Floors on HealthCompletedNCT05914363Not applicable1 country
- Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel AdjuvantCompletedNCT01385189Phase 11 country
- Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administrationCompletedNCT04700423Phase 2/31 country
- Efficacy and Safety of MOX/ALB Co-administrationCompletedNCT04726969Phase 31 country
- Efficacy and Safety of Emodepside in Adolescents and Adults Infected With HookwormCompletedNCT05538767Phase 21 country
- Albendazole Dose Finding and Pharmacokinetics in Children and AdultsCompletedNCT03527745Phase 21 country
- Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and HookwormCompletedNCT05017194Phase 21 country
- Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical CenterCompletedNCT03126552Not applicable1 country
- Hookworm Immune Regulation ProjectStatus unknownNCT02262403Not applicable1 country
- Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese AdultsCompletedNCT03373214Phase 11 country
- Repeated Controlled Human Hookworm InfectionCompletedNCT03257072Not applicable1 country
- Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against HookwormCompletedNCT03995680Phase 21 country
- Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene EducationStatus unknownNCT04227834Not applicable1 country
- Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian AdultsCompletedNCT02476773Phase 11 country
- Immunisation, Treatment and Controlled Human Hookworm InfectionCompletedNCT03702530Not applicable1 country
- Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy AdultsCompletedNCT01717950Phase 11 country
- Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of BrazilCompletedNCT00939198Not applicable1 country
- Triple Combinations Against Hookworm Infections in LaoCompletedNCT03278431Phase 41 country
- Mebendazole Study Against Hookworm Infections in Children and Adolescents in GhanaWithdrawnNCT03261596Phase 41 country
- Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese AdultsCompletedNCT02126462Phase 11 country
- Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian AdultsCompletedNCT01261130Phase 11 country
- Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm InfectionCompletedNCT00120081Phase 11 country
- Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or SchistosomaCompletedNCT01163877Not applicable1 country
- Study to Test Whether Shoes Protect Children Against Hookworm Infection on Pemba Island, ZanzibarCompletedNCT01869127Not applicable1 country
- Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian AdultsTerminatedNCT00473967Phase 11 country
- Development of a Skin Test for the Na-ASP-2 Hookworm AntigenCompletedNCT00603889Not applicable1 country
- Randomised Placebo Controlled Study of Effects of Therapeutic Hookworm Infection in AsthmaCompletedNCT00469989Not applicable1 country
- Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic RhinoconjunctivitisCompletedNCT00232518Not applicable1 country
- Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753Not applicable1 country